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Abstract
Background: COVID-19, the pandemic caused by the severe acute respiratory syndrome coronavirus-2, is
challenging healthcare systems worldwide. Little is known about problems faced by emergency medical services—
particularly helicopter services—caring for suspected or confirmed COVID-19 patients. We aimed to describe the
issues faced by air ambulance services in Europe as they transport potential COVID-19 patients.
Methods: Nine different HEMS providers in seven different countries across Europe were invited to share their
experiences and to report their data regarding the care, transport, and safety measures in suspected or confirmed
COVID-19 missions. Six air ambulance providers in six countries agreed and reported their data regarding
development of special procedures and safety instructions in preparation for the COVID-19 pandemic. Four
providers agreed to provide mission related data. Three hundred eighty-five COVID-19-related missions were
analysed, including 119 primary transport missions and 266 interfacility transport missions.
Results: All providers had developed special procedures and safety instructions in preparation for COVID-19.
Ground transport was the preferred mode of transport in primary missions, whereas air transport was preferred for
interfacility transport. In some countries the transport of COVID-19 patients by regular air ambulance services was
avoided. Patients in interfacility transport missions had a significantly higher median (range) NACA Score 4 (2-5)
compared with 3 (1-7), needed significantly more medical interventions, were significantly younger (59.6 ± 16 vs
65 ± 21 years), and were significantly more often male (73% vs 60.5%).
Conclusions: All participating air ambulance providers were prepared for COVID-19. Safe care and transport of
suspected or confirmed COVID-19 patients is achievable. Most patients on primary missions were transported by
ground. These patients were less sick than interfacility transport patients, for whom air transport was the preferred
method.
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Background
COVID-19, the pandemic caused by the severe acute re-
spiratory syndrome (SARS) coronavirus-2 (SARS-CoV-
2), is challenging healthcare systems worldwide. In some
countries, the number of serious cases has exceeded the
resources available and the health care system’s ability to
cope. By definition this is a disaster situation, and the
SARS-Cov-2 outbreak has been referred to as a mass
casualty incident of the highest degree [1, 2].
The COVID-19 virus is highly contagious and can sur-
vive for up to 5 days on a variety of surfaces [3, 4]. This
is a major problem for healthcare providers who have
close contact with COVID-19 patients for long periods.
This includes the crews of ground emergency medical
services (EMS) and helicopter emergency medical ser-
vices (HEMS). These services have been extremely busy,
with multiple consecutive transport missions.
The healthcare providers and transferred patients are
at high risk of infection if the ambulances and aircrafts
are insufficiently disinfected before the next mission [5].
Possible ways of infection include respiratory droplets /
aerosols, direct / indirect contact with contaminated se-
cretions or surfaces, and medical interventions (e.g. air-
way management, suction of secretion, CPR) which
increase the risk of virus transmission [1, 5–8]. There-
fore, a strong hygiene concept, proper personal protect-
ive equipment (PPE), standard operating procedures
(SOPs), and occasional access to special equipment are
of utmost importance when managing patients with sus-
pected or confirmed COVID-19 infection. It is very im-
portant to clean and disinfect the ambulances and
aircrafts upon arrival at their final home base [9].
Until now, data on COVID-19 patients’ care and trans-
port by air ambulance systems across Europe are very
limited [10]. We aimed to describe how six different
HEMS/air ambulance systems based in Europe cared for
patients with confirmed or suspected COVID-19.
Methods
Settings
Nine physician staffed air ambulance providers in seven
European countries were invited to participate in the
study, to give information, and to share their experiences
when transporting COVID-19 patients (see Figure S1
and Table S1 regarding information of the invited and
participating countries). In the light of the spreading of
the SARS-CoV-2 across Europe, the invited air ambu-
lance providers were asked to provide data regarding the
development of special instructions and safety proce-
dures in preparation for missions with suspected or con-
firmed COVID-19 patients.
Of the nine invited air ambulance providers, six agreed
to participate. The participating providers were based in
six European countries and agreed to provide the follow-
ing information (listed in alphabetic order):
1. Austria: The ARA-Air Rescue Austria, which uses
only helicopters for air ambulance service, provided
data regarding preparation, special procedures and
safety instruction for COVID-19-related missions.
2. Denmark: The Danish Air Ambulance mainly uses
helicopters for patient transport, but occasionally
transfers patients in road ambulances. It provided
data regarding preparation, special procedures and
safety instructions for COVID-19-related missions.
The database of the service was used to identify
COVID-19-related missions.
3. Germany: The DRF-Luftrettung (German air res-
cue) service, which mainly uses helicopters and to a
minor degree fixed-wing aircraft, provided data re-
garding preparation, special procedures and safety
instructions for COVID-19-related missions. The
database of the service was used to identify
COVID-19-related missions.
4. Luxembourg: The LAR-Luxembourg Air Rescue
service, which uses helicopters and fixed-wing air-
craft, provided data regarding preparation, special
procedures and safety instructions for COVID-19-
related missions. The service’s database was ana-
lysed to identify COVID-19-related missions.
5. Norway: The Norwegian Air Ambulance service,
which uses helicopters and fixed-wing aircraft, pro-
vided data regarding preparation, special procedures
and safety instructions for COVID-19-related
missions.
6. Switzerland: The Swiss Air Rescue service Rega,
which uses helicopters and fixed-wing aircrafts pro-
vided data regarding preparation, special procedures
and safety instructions for COVID-19-related mis-
sions. The database was used to identify COVID-
19-related missions.
Patient isolation units
Different providers have special patient isolation units
(PIUs) in stock for transport of infectious patients, which
can also be used to transport COVID-19 patients. The
most common PIUs are the EpiShuttel® and the REGA
PIU. The Epishuttle® is a CE 1789 compliant reusable
single-patient isolation and transport system that can be
used in ambulances, helicopters and airplanes. The shut-
tle can either be used to protect the surroundings from
an infectious patient or to protect the patient from the
surroundings. During transport, the medical crew does
not need to wear full personal protective equipment.
The EpiShuttle® is equipped with different ports (oper-
ator ports, wire port, ventilator port) and a ventilation
system that generates more than 15 air exchanges per
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hour and can be used with negative or positive pressure
inside, depending on who needs to be protected (the pa-
tient or the crew). The Rega PIU comprises a flexible
safety hull stabilised by arched wires mounted on a hard
floor plate. It is maintained under negative pressure by a
high-efficiency particulate air filtered ventilation system
that uses aircraft power and/or battery power. The PIU
barrier performance has proven equal to that provided
by protective clothing. Its fixation system allows trans-
portation on any commonly available patient stretcher.
The PIU is designed to fit in a fixed-wing ambulance, a
medium-sized helicopter, and ground-based ambulances
[10].
Data variables
Four air ambulance providers (see above) agreed to pro-
vide data of COVID-19-related missions. Of these
COVID-19-related missions, the following variables were
studied:
1. General data: Age, gender, National Advisory
Committee for Aeronautics (NACA) Score,
suspected or confirmed SARS-CoV-2 infection.
2. Mode of transport: Ground ambulance
accompanied by doctor, ground ambulance without
HEMS doctor attendance, helicopter transport,
fixed-wing aircraft transport, transport to maximum
care hospital or basic care hospital, no transport to
medical facility.
3. Medical interventions during missions:
intravenous (i.v.) access, fluid therapy, drug
administration, oxygen therapy, non-invasive venti-
lation (NIV), airway management, lung ultrasound,
cardiopulmonary resuscitation (CPR) including the
use of an automated chest compression device
(ACCD), extracorporeal membrane oxygenation
(ECMO).
4. Hygiene: face mask for spontaneously breathing
patients, use of a filtering face piece (FFP) mask by
the crew, use of common surgical face masks by the
crew, use of safety glasses/goggles by the crew, use
of complete personal protective equipment, final
disinfection of the aircraft, use of a PIU.
Data collection
All missions from February 1, 2020, to April 30, 2020,
were included in the retrospective data collection and
analysis. The data management systems of the providers
agreed to provide mission related information were ana-
lysed regarding general data of potential COVID-19-
related missions and the above mentioned study
variables.
Statistical analysis
COVID-19-related primary missions were compared
with interfacility transport missions regarding general
data, mode of transport, medical interventions and hy-
gienic procedures. Data are presented as number (%),
mean (SD), or median (range) as appropriate. Fisher’s
exact test was used to compare the categorical data of
two independent groups, while the Mann-Whitney U
test was used to compare continuous or ordinal data of
two independent groups. Nonparametric statistical
methods were used to compare these groups because
these methods compare the ranks and not the crude
numbers, without the need for a normal distribution or
equal variance of the data, and they protect against small
numbers of events. A p value of less than 0.05 was con-
sidered significant. Statistical analyses were performed
using GraphPad Prism 8 for Windows (GraphPad Soft-
ware 2020, LLC).
Ethics
The study is in line with the current European general
data protection regulation (GDPR).
Results
During the study period, the participating air ambu-
lances cared for 385 potential COVID-19 patients with a
mean age of 61.3 ± 10.8 years and 266 of these were
males (69%).The median (range) NACA-Score of these
385 patients was 4 (1-7) and 233 patients (60,5%) had
confirmed COVID-19.
Special procedures and safety instructions
A majority of the European countries participating had
some time to prepare a response to the expected corona
pandemic. Accordingly, all participating air ambulance
providers used this time to develop special procedures
and safety instructions for managing COVID-19 patients
(e.g., SOPs regarding intubation, lung ultrasound, CPR,
PPE, terminal disinfection). The safety instructions of all
providers are very similar (see Fig. 1) and are based on
national and international recommendations. Because
there was a shortage of proper PPE at the beginning of
the pandemic, the safety instructions for PPE use were
adjusted according to the availability of protective equip-
ment. During the beginning of the pandemic, PPE has
only been used in cases of suspicion or in patients stay-
ing in high-risk areas within the last 2 weeks. Sufficient
for all missions, PPE were available at the beginning of
April. Most missions with any patient contact were car-
ried out with FFP 2/N95 masks and gloves. Depending
on further medical interventions and virus transmission
risk, a stepwise extension to full PPE (gloves, a fluid-
repellent long-sleeved gown or other protective clothing,
eye protection, and an FFP 3 mask) was recommended.
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The aircrafts were supplied with additional full PPE and
additional surgical facemasks for spontaneously breath-
ing patients. The aeromedical crews were trained in the
proper use of the PPE. For safe transport of patients with
confirmed COVID 19 infection, three providers already
had special single-patient isolation units (PIUs) and one
provider equipped some of the HEMS bases with new
PIUs (Fig. 2).
Transportation of COVID-19 patients
Table 1 shows the COVID-19 mission data over a
three-month period (February–April 2020). During
that period, the participating air ambulances flew
8340 primary missions and 3029 interfacility transport
missions, caring for 385 potential COVID-19 patients.
Of these patients, 233 had confirmed COVID-19 in-
fections (60.5%) and 152 had suspected COVID-19 in-
fections (39.5%). For 119 of the patients (31%) it was
a primary mission and for 266 it was an interfacility
transport (69%). The characteristics of the patients
transferred in primary missions and interfacility
transport were significantly different (Table 1). Inter-
facility transport patients had a higher rate of con-
firmed COVID-19, were younger, were more often
male, and were more severely ill (as reflected by the
higher NACA score).
There were significant differences in the mode of
transport used by the air ambulance services for primary
and interfacility transport missions. Ground transport
was the preferred mode of transport in primary missions
(72%), with 28.6% of patients being transported without
a physician present. On the other hand, air transport
was preferred for interfacility transport (87%). In some
countries (Denmark, Norway), transport by regular
HEMS was generally avoided. Only COVID-19 patients
with a true time-critical condition were transported in
an HEMS aircraft, which is a safer and faster method.
All other transport missions in both countries were car-
ried out by the Search and Rescue (SAR) service of the
armed forces. The 48 long-distance flights (i.e., between
European countries and overseas) were carried out by
fixed-wing aircraft.
Fig. 1 A decision tree for use in evaluating safe transfer during COVID-19-related missions. This one, from the DRF-Luftrettung, is the “Primary
mission algorithm for aeromedical crews”
Hilbert-Carius et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2020) 28:94 Page 4 of 10
The majority of patients treated needed medical
interventions during the missions. Table 1 summarises
some of the typical emergency and intensive care inter-
ventions. Patients who needed to be transferred to a
higher-level medical facility (mainly interfacility trans-
port) were more severely ill and needed significantly
more mission-related interventions, except fluid therapy.
Non-invasive ventilation (NIV), lung ultrasound and
CPR—including ACCD —was used significantly more
often in primary missions. During interfacility transport,
ECMO was vital to ensure sufficient oxygenation in 14
patients (5.3%).
Table 1 shows the hygienic measures taken to keep
the risk of SARS-CoV-2 infection as low as possible for
both the aeromedical crew and patients. Because there
were significantly more confirmed COVID-19 patients
in interfacility transport, there were also significant dif-
ferences in the hygienic measures reported, except for
the final disinfection of the aircraft. During the missions,
none of the aeromedical crew members were infected
with SARS-CoV-2. Forty-three patients were transported
using a PIU, including 23 in the EpiShuttle® (Fig. 2) and
20 in the Rega-owned PIU (Fig. 3).
Discussion
Ground emergency medical services and HEMS are part
of the medical chain in the care of patients with
COVID-19. Due to the pandemic, they are faced with
new challenges, and different countries and health care
systems vary in their reactions to the problem. Our
Fig. 2 The EpiShuttle® of the DRF-Luftrettung (©DRF-Luftrettung – Germany). The EpiShuttle is used only for interfacility transport. It is fitted into
the helicopter (EC 145 / H 145) before the mission. The DRF-Luftrettung has an exemption according to article 71 (1) of regulation (EU) 2018/
1139 by the “Luftfahrt-Bundesamt – LBA” (civil aeronautics board of Germany) to use the EpiShuttle in the Eurocopter 145 and Airbus Helicopter
145 rotor wing aircrafts of the company
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Table 1 Comparison between primary missions and interfacility transport for COVID-19 related missions by four air ambulance
providers from four countries between February 1 and April 30, 2020. Data are presented as mean (SD), median (range), or number
(%) as appropriate. *Percentage totals are greater than 100% because 11 patients were transported by both airplane and helicopter
Primary missions Interfacility transport p value
Total number of missions during study period 8340 3029 < 0.001
General data
Number of patients (% of missions) 119 (1.4%) 266 (8.8%)
Age of patients, mean (SD) 65.1 (21) 59.6 (6.2) < 0.01
Male (%) 72 (60.5%) 194 (73%) 0.017
NACA Score, median (range) 3 (1–7) 4 (2–5) < 0.001
Suspected COVID-19 100 (84%) 52 (19.5%) < 0.001
Confirmed COVID-19 19 (16%) 214 (80.5%) < 0.001
Mission-related complications 2 (1.7%) 4 (1.5%) 0.99
Mode of transport
Ground ambulance accompanied by doctor 52 (44%) 42 (16%)* < 0.001
Ground ambulance without HEMS doctor attendance 34 (28.5%) 12 (4.5%)* < 0.001
Helicopter transport 19 (16%) 184 (69%)* < 0.001
Fixed-wing aircraft transport 0 48 (18%)* < 0.001
Transport to
maximum care hospital 64 (54%) 177 (66.5%) 0.022
basic care hospital 39 (33%) 10 (4%) < 0.001
No transport to medical facility 14 (11.5%) 1 (0.5%)* < 0.001
Medical interventions during mission
i.v. access 107 (90%) 261 (98%) < 0.001
Fluid therapy 92 (77%) 235 (88%) < 0.01
Drug administration 60 (50%) 225 (84.5%) < 0.001
Oxygen therapy 33 (28%) 205 (77%) < 0.001
NIV 5 (4%) 0 0.002
Airway management 18 (15%) 189 (70%) < 0.001
Lung ultrasound 8 (7%) 6 (2%) 0.039
CPR/use of ACCD 9 (7.5%) 1 (0.5%) < 0.001
ECMO in total 0 14 (5%) 0.006
vv-ECMO 0 9 (3%) 0.062
va-ECMO 0 5 (2%) 0.329
Hygienic procedures
Facemask for spontaneously breathing patients 95 (80%) 86 (32%) < 0.001
FFP 2 (N 95) / FFP 3 (N 99) mask 82 (68%) 161 (60.5%) 0.137
Common surgical face mask 54 (45%) 87 (33%) 0.022
Safety glasses/goggles 82 (68%) 251 (94%) < 0.001
Complete personal protective equipment 38 (32%) 176 (66%) < 0.001
Final disinfection of aircraft 118 (99%) 266 (100%) 0.309
Use of PIU in total 0 43 (16%) < 0.001
EpiShuttle® 0 23 (8.5%) < 0.001
Rega PIU 0 20 (7.5%) < 0.001
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study’s data demonstrate that, although care and trans-
port of COVID-19 patients may be handled in different
ways in different European countries, it is nevertheless
safe. As the number of patients with COVID-19 could
increase, however, aeromedical crews must be able to
adapt.
Preparation of COVID-19 missions
All participating air ambulance providers developed
special procedures and safety instructions to be
followed when transferring COVID-19 patients, in-
cluding equipping the aircrafts with full PPE, and
training their crews in its proper use. This and the
training of crews in how to deal with COVID-19 pa-
tients could have contributed to the fact that no
COVID-19 infections were reported in crew members
flying these missions. During the “hot period” of the
pandemic, it was difficult to get supply of PPE and
disinfectant on short term basis, but the involved air
ambulance providers never went out of stock.
Mode of transport
At present, ground transport of COVID-19 patients
seems to be the preferred mode of transport when car-
ing for patients in a primary mission. This data is in line
with recommendations across Europe [10]. On the con-
trary, for interfacility transport, air is the preferred
mode. Both strategies have advantages and disadvan-
tages. Finding the balance between ground and air trans-
port is a challenge for the HEMS crews.
In a primary mission for a noncritical patient who
needs further medical treatment in a hospital, transport
by ground ambulance without physician attendance is
practical, safe and resource sparing. In the case of
Fig. 3 PIU owned by the REGA (©REGA - Switzerland). The REGA PIU is mainly used in the fixed wing aircrafts (Challenger 650) of the company.
Transport of 2 PIU per flight are possible in the Challenger 650
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critically ill patients, the HEMS team has to decide
whether an HEMS physician should accompany the pa-
tient and which mode of transport is most useful, taking
into account the distance to the hospital, possible
changes of equipment, potential deterioration of the
patient during transport, and the need for final disin-
fection. After air transport of a COVID-19 patient,
the aircraft is out of service until the final disinfec-
tion, if no PIU was used.
Patients in critical condition who are being transferred
to a higher-level care facility may need medical interven-
tions en route. Air transport is the logical method in
many of these cases. Data in the literature show that pa-
tients who are transferred using expedited helicopter
transfer protocols have better post-transfer survival [11].
In the near future, it is possible, that the air transport of
COVID-19 suspected patients in primary missions will
increase, depending on the NACA score and the critical
condition of the patient.
In the study involved Scandinavian countries, HEMS
transport of COVID-19 patients is avoided, with the
search and rescue (SAR) service of the armed forces be-
ing in charge instead. Denmark, for example, like many
other European countries, has a tight network of
ground-based pre-hospital critical care services, and
rapid-response vehicles are staffed with consultant
anaesthetists and paramedics. Most COVID-19 patients
in Denmark were transported by these services in collab-
oration with the local EMS. Patients from islands not at-
tached to the Danish mainland who are suspected of
having or confirmed to have COVID-19 are as a rule
transported in the Merlin 101 SAR helicopters. These
are operated by the Danish Air Force, with critical care
capabilities provided by physician-paramedic teams from
the Central Denmark Region. These teams are using the
EpiShuttle® to isolate patients during transport. In
Norway, the procedure of dealing with COVID-19 pa-
tients is similar to Denmark.
Cooperation among countries
In some countries, the number of serious cases was
beyond what the health system could accommodate
while still maintaining high European standards of
care. Accordingly, some serious cases were trans-
ported to neighbouring European countries with add-
itional intensive care capacity. Long-distance transport
was primarily performed by fixed-wing aircraft, as was
repatriation of European inhabitants from overseas.
Especially the REGA and LAR fixed wing air ambu-
lance services transported COVID-19 patients from
south of Europe (Spain, Italy, and France) to central
European countries like Germany, Switzerland,
Luxembourg. The DRF-Luftrettung used EpiShuttel®
equipped helicopters for cross-border transport be-
tween France and Germany. Figure S1 shows the
cross-border interfacility transports of the study in-
volved air ambulance providers.
Medical interventions
Many medical interventions were carried out in emer-
gency situations, such as airway management and suc-
tion which are associated with high risk of
contamination. Therefore, it is of utmost importance to
equip the EMS and HEMS with PPE to wear when tak-
ing care of patients with suspected or confirmed
COVID-19. Modern air ambulance services are able to
provide advanced interventions during transport, includ-
ing intensive care procedures, differentiated catechol-
amine therapy, volume resuscitation, modern ventilation
strategies, ECMO, inhaled nitric oxide, or even the use
of heart-assisted devices (e.g. like Impella®) during trans-
port [12–15]. Several guidelines recommend the use of
ECMO or inhaled nitric oxide in selected COVID-19 pa-
tients. Some patients may deteriorate quickly and need
ECMO during transport (Table 1) [16, 17].
Fluid therapy and drug administration are common in
emergency medicine and intensive care, and are per-
formed in COVID-19 patients as well. Surprisingly, the
use of lung ultrasound in the pre-hospital setting is very
limited, although it could help diagnose emergency pa-
tients with dyspnoea. Portable point-of-care ultrasound
(POCUS) is a safe and effective bedside pre-hospital tool
which can be used for initial evaluation and manage-
ment in patients with confirmed or suspected COVID-
19 infection [18]. The data of our survey show that even
in modern, well-equipped European air ambulance sys-
tems with highly trained specialists, the potential for im-
provement in pre-hospital POCUS exists.
Infection status and hygiene
Due to lack of information on infection status and lim-
ited resources and space, the risk of virus transmission
in a helicopter or airplane is possibly higher than for in-
hospital healthcare providers. Furthermore, many med-
ical interventions increase the risk of virus transmission
[5–8]. Examples are non-invasive ventilation (NIV), air-
way management, CPR, or even recording an electrocar-
diogram (ECG) [8, 19, 20]. Similar to SARS-CoV-1
patients, there are some COVID-19 patients who are
“superspreaders” with a very high transmission rate [8].
Therefore, it is of utmost importance to equip the EMS
and HEMS with PPE to wear when taking care of
patients with suspected or confirmed COVID-19.
Appropriate PPE is therefore recommended [21]. If in-
formation about potential COVID-19 has not been pro-
vided, initial assessment, if possible, should begin from a
distance of at least 2 m from the patient [21]. During
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medical care, a facemask should be worn by the patient,
and if transport is necessary, the number of health-
care providers in the patient compartment should be
limited to a minimal number [21]. PPE should be
matched to the potential mode of viral transmission,
including contact (gloves, apron), droplet (gloves,
apron, eye protection, FFP 2/N95 mask), or airborne
(gloves, fluid-repelling long-sleeved gown, eye protec-
tion, FFP 3 mask) [21–23].
Interfacility transport missions can be very exhausting
and physically stressful for the medical team. They often
involve several hours of work in full PPE, conditions
which may contribute to medical errors [24]. Therefore
COVID-19 patients are increasingly being transferred in
fixed-wing aircraft and helicopters containing PIUs like
the EpiShuttle® or the Rega PIU. Due to the SARS-CoV-
2 pandemic, some providers (like the DRF-Luftrettung)
have equipped several HEMS bases with PIUs for safe
transport of confirmed COVID-19 patients. As a result
of the effective protection of the HEMS crew during
transport of SARS-CoV-2 patients, helicopters do not
have to be disinfected after patient transport if a PIU is
used. Accordingly, the aircraft can remain in operation
longer.
Limitations of the study
Our study has some limitations with a relatively short
study period in a fast changing pandemic situation. First,
it presents a selection of European HEMS providers, and
cannot be generalized for all European air ambulance
services. All studied services were physician staffed and
the results may not apply to non-physician staffed ser-
vices. Second, not all invited providers were able to re-
port COVID-19 patients’ mission-related data because
COVID-19 patients were transported by the SAR service
of the armed forces in their country. We do not have
any information about patients’ comorbidity or hospital
mortality. Third, European countries with a very high in-
cidence of COVID-19, like Italy, France and Spain, did
not participate in this study. Nevertheless, this study
clearly shows that safe care during long transport of
COVID-19 patients is achievable.
Conclusions
Participating air ambulance providers were prepared in
advance for COVID-19-related missions. Safe care and
transport of suspected or confirmed COVID-19 patients
is achievable. Most patients transferred after on-scene
calls are transported by ground. These patients tend to
be less sick than patients being transferred from one fa-
cility to another, whom needed significantly more
mission-related interventions. Air transport was the pre-
ferred method for these patients, and long-distance
flights were carried out by fixed-wing aircrafts.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13049-020-00789-8.
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Abbreviations
ACCD: Automated chest compression device; CE 1789: European Union
standard for ambulances; COVID-19: Coronavirus disease 19;
CPR: Cardiopulmonary resuscitation; EC: Eurocopter; ECG: Electrocardiogram;
ECMO: Extracorporeal membrane oxygenation; EMS: Emergency medical
service; FFP: Filtering face piece; H: Airbus helicopter; HEMS: Helicopter
emergency medical service; i.v.: Intravenous; NACA: National Advisory
Committee for Aeronautics; NIV: Non-invasive ventilation; PIU: Patient
isolation unit; PPE: Personal protective equipment; SAR: Search and Rescue;
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; SD: Standard
deviation; va: Veno-arterial; vv: Veno-venous
Acknowledgements
The authors would like to thank the following air ambulance providers for
participating in this study (in alphabetical order):
ARA/Air Rescue Austria – Austria
Den Landsdækkende Akutlægehelikopterording / Danish Air Ambulance –
Denmark
DRF-Luftrettung / German Air Rescue – Germany
LAR/Luxembourg Air Rescue – Luxembourg
Norsk Luftambulanse/Norwegian Air Ambulance – Norway
Swiss Air Rescue REGA – Switzerland
Special thanks to Jeannie Wurz (Bern University Hospital, Switzerland) for her
help with the English and her valuable comments on the manuscript.
Authors’ contributions
P.H-C., F.A-Z. & J.B. developed the study and wrote the first manuscript draft.
D.B., J.A., R.A., D.D., P.A., L.R. & J. K., were involved in the data analysis and the
improvement of the manuscript. Statistical analysis was done by P.H-C., F.A-Z.
& R.A. All authors read and approved the final manuscript.
Funding
None.
Availability of data and materials
The dataset generated and analysed during the current study are not
publicly available due the ownership of the different air ambulance providers
but are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Not applicable.
The study is in line with the current European general data protection
regulation (GDPR).
Consent for publication
Not applicable.
Competing interests
The authors declare that there is no conflict of interest regarding the
publication of this paper.
Author details
1Department of Anaesthesiology, Intensive Care and Emergency Medicine,
Pain Therapy, BG-Klinikum Bergmannstrost Halle (Saale), Merseburgerstr 165,
06112 Halle (Saale), Germany. 2DRF-Luftrettung (German Air Rescue), HEMS
Christoph 84 and Christoph 85 Halle (Saale), Halle (Saale), Germany. 3Faculty
of Medicine -Wissenschaftlicher Arbeitskreis der DRF Stiftung Luftrettung
(German Air Rescue) gemeinnützige AG, Filderstadt, Germany. 4Department
of Surgery, College of Medicine and Health Science, UAE University, Al-Ain,
United Arab Emirates. 5LAR-Luxembourg Air Rescue, Sandweiler,
Luxembourg. 6Department of Anaesthesiology and Pain Medicine, Inselspital,
Bern University Hospital, University of Bern, Bern, Switzerland. 7Swiss Air
Hilbert-Carius et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2020) 28:94 Page 9 of 10
Rescue Rega, Zürich, Switzerland. 8Department of Anaesthesiology and
Intensive Care Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
9Department of Anaesthesia, Aarhus University Hospital, Aarhus, Denmark.
10Den Landsdækkende Akutlægehelikopterording (Danish Air Ambulance),
Aarhus, Denmark.
Received: 7 July 2020 Accepted: 10 September 2020
References
1. Kahn G, Sheek-Hussein M, Al Suwaidi A, Idris K, Abu-Zidan F. Novel
coronavirus pandemic: A global health threat. Turk J Emerg Med. 2020;20(2):
55–62.
2. Coccolini F, Sartelli M, Kluger Y, Pikoulis E, Karamagioli E, Moore EE, et al.
COVID-19 the showdown for mass casualty preparedness and management:
the Cassandra syndrome. World J Emerg Surg. 2020;15(1):26.
3. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on
inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect.
2020;104(3):246–51.
4. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High
Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome
Coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–7.
5. Wilson NM, Norton A, Young FP, Collins DW. Airborne transmission of
severe acute respiratory syndrome coronavirus-2 to healthcare workers: a
narrative review. Anaesthesia. 2020;75(8):1086–95.
6. Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, Tang P, et al.
Transmission of severe acute respiratory syndrome during intubation and
mechanical ventilation. Am J Respir Crit Care Med. 2004;169(11):1198–202.
7. Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should
face the reality. Environ Int. 2020;139:105730.
8. Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D,
et al. Risk factors for SARS transmission from patients requiring
intubation: a multicentre investigation in Toronto, Canada. PLoS One.
2010;5(5):e10717.
9. Liew MF, Siow WT, Yau YW, See KC. Safe patient transport for COVID-19. Crit
Care. 2020;24(1):94.
10. Albrecht R, Knapp J, Theiler L, Eder M, Pietsch U. Transport of COVID-19 and
other highly contagious patients by helicopter and fixed-wing air
ambulance: a narrative review and experience of the Swiss air rescue Rega.
Scand J Trauma Resusc Emerg Med. 2020;28(1):40.
11. Reimer AP, Dalton JE. Predictive accuracy of medical transport information
for in-hospital mortality. J Crit Care. 2018;44:238–42.
12. Vieira J, Frakes M, Cohen J, Wilcox S. Extracorporeal membrane oxygenation
in transport part 2: complications and troubleshooting. Air Med J. 2020;
39(2):124–32.
13. Vieira J, Frakes M, Cohen J, Wilcox S. Extracorporeal membrane oxygenation
in transport part 1: extracorporeal membrane oxygenation configurations
and physiology. Air Med J. 2020;39(1):56–63.
14. Yao H, Samoukovic G, Farias E, Cimone S, Churchill-Smith M, Jayaraman D.
Safety and flight considerations for mechanical circulatory support devices
during air medical transport and evacuation: a systematic narrative review
of the literature. Air Med J. 2019;38(2):106–14.
15. Buskop C, Bredmose PP, Sandberg M. A 10-year retrospective study of
interhospital patient transport using inhaled nitric oxide in Norway. Acta
Anaesthesiol Scand. 2015;59(5):648–53.
16. Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C.
Recommendations for critically ill patients with COVID-19. Med Klin
Intensivmed Notfmed. 2020;115(3):175–7.
17. WHO. Clinical management of severe actute respiratory infection when
novel coarona virus (nCoV) infection is suspected: Interim guidance: WHO;
2020. Available from: https://www.who.int/publications-detail/clinical-
management-of-severe-acute-respiratory-infection-when-novel-coronavirus-
(ncov)-infection-is-suspected.
18. Convissar D, Gibson LE, Berra L, Bittner EA, Chang MG. Application of lung
ultrasound during the COVID-19 pandemic: a narrative review. Anesth
Analg. 2020;131(2):345–50.
19. Thomas-Ruddel D, Winning J, Dickmann P, Ouart D, Kortgen A, Janssens U,
et al. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and
intensivists March 2020. Anaesthesist. 2020;69(4):225–35.
20. Edelson DP, Sasson C, Chan PS, Atkins DL, Aziz K, Becker LB, et al. Interim
Guidance for Basic and Advanced Life Support in Adults, Children, and
Neonates With Suspected or Confirmed COVID-19: From the Emergency
Cardiovascular Care Committee and Get With The Guidelines-Resuscitation
Adult and Pediatric Task Forces of the American Heart Association.
Circulation. 2020;141(25):e933–43. https://doi.org/10.1161/CIRCULATIONAHA.
120.047463.
21. CDC. Interim Guidance for Emergency Medical Services (EMS) Systems amd
911 Public Safety Answering Pionts (PSAPs) for COVID-19 in the United
States. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/
hcp/guidance-for-ems.html.
22. Cook TM. Personal protective equipment during the coronavirus disease
(COVID) 2019 pandemic - a narrative review. Anaesthesia. 2020;75(7):920–7.
23. NHS. COVID-19: guidance for Ambulance Trusts 2020 [updated 11 April
2020. Available from: https://www.gov.uk/government/publications/covid-1
9-guidance-for-ambulance-trusts.
24. Radonovich LJ Jr, Cheng J, Shenal BV, Hodgson M, Bender BS. Respirator
tolerance in health care workers. JAMA. 2009;301(1):36–8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Hilbert-Carius et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2020) 28:94 Page 10 of 10
